rs137852571
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 3P and 6B. PM1PP2BP4_ModerateBS2
The NM_000044.6(AR):c.2191G>A(p.Val731Met) variant causes a missense change. The variant allele was found at a frequency of 0.000024 in 1,210,381 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000036 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000023 ( 0 hom. 11 hem. )
Consequence
AR
NM_000044.6 missense
NM_000044.6 missense
Scores
4
7
5
Clinical Significance
Conservation
PhyloP100: 4.27
Publications
9 publications found
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
- androgen insensitivity syndromeInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- Kennedy diseaseInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- partial androgen insensitivity syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- complete androgen insensitivity syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PM1
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 5 uncertain in NM_000044.6
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 147 curated pathogenic missense variants (we use a threshold of 10). The gene has 39 curated benign missense variants. Gene score misZ: 1.2272 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to androgen insensitivity syndrome, Kennedy disease, complete androgen insensitivity syndrome, partial androgen insensitivity syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.21336913).
BS2
High Hemizygotes in GnomAdExome4 at 11 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000356 AC: 4AN: 112311Hom.: 0 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
4
AN:
112311
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000766 AC: 14AN: 182820 AF XY: 0.000104 show subpopulations
GnomAD2 exomes
AF:
AC:
14
AN:
182820
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000228 AC: 25AN: 1098018Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 11AN XY: 363412 show subpopulations
GnomAD4 exome
AF:
AC:
25
AN:
1098018
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
363412
show subpopulations
African (AFR)
AF:
AC:
1
AN:
26402
American (AMR)
AF:
AC:
0
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19382
East Asian (EAS)
AF:
AC:
7
AN:
30175
South Asian (SAS)
AF:
AC:
6
AN:
54115
European-Finnish (FIN)
AF:
AC:
0
AN:
40523
Middle Eastern (MID)
AF:
AC:
0
AN:
4090
European-Non Finnish (NFE)
AF:
AC:
5
AN:
842047
Other (OTH)
AF:
AC:
6
AN:
46079
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000356 AC: 4AN: 112363Hom.: 0 Cov.: 23 AF XY: 0.0000289 AC XY: 1AN XY: 34543 show subpopulations
GnomAD4 genome
AF:
AC:
4
AN:
112363
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34543
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30932
American (AMR)
AF:
AC:
0
AN:
10681
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2657
East Asian (EAS)
AF:
AC:
3
AN:
3550
South Asian (SAS)
AF:
AC:
1
AN:
2697
European-Finnish (FIN)
AF:
AC:
0
AN:
6152
Middle Eastern (MID)
AF:
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
AC:
0
AN:
53262
Other (OTH)
AF:
AC:
0
AN:
1529
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Prostate cancer Pathogenic:1
May 04, 2022
Mendelics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Prostate cancer, somatic Pathogenic:1
Apr 01, 1995
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Mar 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Pathogenic
D
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;D
REVEL
Pathogenic
Sift
Uncertain
.;D;D
Sift4G
Uncertain
D;D;D
Vest4
MVP
MPC
0.46
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.